SCHEMBL4026431

SCHEMBL4026431

OCC1=COCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4753907 0.70
SCHEMBL14631160 0.64
SCHEMBL3720483 0.64
SCHEMBL4446045 0.63
SCHEMBL3073245 0.61
SCHEMBL9619300 0.60
SCHEMBL9569884 0.57
SCHEMBL991267 0.55
SCHEMBL28315368 0.54
SCHEMBL6873550 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0851864-B1 NOVEL COUPLING AGENTS, PROCESSES FOR THEIR PREPARATION AND HAIR DYES SCHWARZKOPF GMBH HANS (DE) 2001-05-23 EP claimed
EP-0851864-A1 NOVEL COUPLING AGENTS, PROCESSES FOR THEIR PREPARATION AND HAIR DYES Hans Schwarzkopf GmbH & Co. KG (DE) 1998-07-08 EP claimed
WO-1997010237-A1 NOVEL COUPLING AGENTS, PROCESSES FOR THEIR PREPARATION AND HAIR DYES HANS SCHWARZKOPF GMBH & CO. KG (DE) 1997-03-20 WO claimed
CN-116284188-B Double-substrate inhibitor of DNA methyltransferase DNMT1 and application thereof 南开大学 2024-07-26 CN disclosed
CN-114502161-B Use of heterocyclic derivatives with cardiomyocyte proliferative activity in the treatment of heart diseases 上海市东方医院(同济大学附属东方医院) 2024-03-29 CN disclosed
CN-116284188-A Double-substrate inhibitor of DNA methyltransferase DNMT1 and application thereof 南开大学 2023-06-23 CN disclosed
CN-110573509-B MLKL inhibitors 北京生命科学研究所 2023-05-26 CN disclosed
CN-114929690-B Novel heterocyclic derivatives having cardiomyocyte proliferative activity for the treatment of heart disease 同济大学 2023-05-05 CN disclosed
CN-114929690-A Novel heterocyclic derivatives with cardiomyocyte proliferative activity for the treatment of cardiac diseases 同济大学 2022-08-19 CN disclosed
CN-108690016-B Pyrazolopyridines and uses thereof 广东东阳光药业有限公司 2022-08-12 CN disclosed
CN-109563043-B Substituted pyridines as inhibitors of DNMT1 葛兰素史密斯克莱知识产权发展有限公司 2022-05-31 CN disclosed
US-5658943-A VASODILATOR FOR CARDIOVASCULAR DISORDER, HYPOTENSIVE AGENT WARNER-LAMBERT COMPANY (US) 1997-08-19 US disclosed
WO-1997020000-A2 IMPROVED COLORANT STABILIZERS KIMBERLY-CLARK WORLDWIDE, INC. (US) 1997-06-05 WO disclosed
WO-1997010237-A1 NOVEL COUPLING AGENTS, PROCESSES FOR THEIR PREPARATION AND HAIR DYES HANS SCHWARZKOPF GMBH & CO. KG (DE) 1997-03-20 WO disclosed
US-5599522-A CONTRAST ENHANCING AGENTS NYCOMED IMAGING AS (NO) 1997-02-04 US disclosed
EP-0515458-B1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI NYCOMED INNOVATION AB (SE) 1995-08-23 EP disclosed
EP-0515458-A1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI. HAFSLUND NYCOMED INNOVATION (SE) 1992-12-02 EP disclosed
WO-1991012024-A1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI HAFSLUND NYCOMED INNOVATION AB (SE) 1991-08-22 WO disclosed
EP-0189586-B1 PROCESS FOR THE PREPARATION OF SALTS OF 1,3-DIOXOLANE-4-CARBOXYLIC ACIDS Henkel Kommanditgesellschaft auf Aktien (DE) 1989-05-24 EP disclosed
EP-0189586-A1 Process for the preparation of salts of 1,3-dioxolane-4-carboxylic acids Henkel Kommanditgesellschaft auf Aktien (DE) 1986-08-06 EP disclosed